Defensive, Play

A Defensive Play: How This Healthcare ETF Aims to Deliver Monthly Income

21.03.2026 - 01:57:46 | boerse-global.de

Brompton Funds' active healthcare ETF, targeting giants like J&J and Eli Lilly, uses covered calls for monthly income. It saw $1.1M inflows as investors seek defensive plays in 2026.

A Defensive Play: How This Healthcare ETF Aims to Deliver Monthly Income - Foto: über boerse-global.de

In a forecast issued in March 2026, Brompton Funds identified the healthcare sector as a potential top performer for the year. Their vehicle for this outlook, the Brompton Global Healthcare H ETF, seeks to provide investors with exposure to major pharmaceutical companies while employing an active options strategy designed to produce regular monthly distributions. Recent fund flows suggest a growing investor appetite for this type of defensive stability amidst ongoing market volatility.

Core Holdings and a Call for Income

The fund’s management selects individual equities based on fundamental criteria, including valuation, profitability, and balance sheet strength. Its concentrated portfolio is built around industry titans such as Johnson & Johnson, Novartis, and Eli Lilly. These firms are seen as primary beneficiaries of powerful, long-term demographic and innovation trends, including an aging global population.

To this equity base, the actively managed ETF adds a covered-call program. This involves writing call options on the underlying stock holdings. The dual objectives of this strategy are to generate supplemental monthly income and to help reduce the overall volatility of the portfolio.

Investor Reception and Fund Details

This combined approach appears to be resonating with the market. Over a one-month period concluding in mid-February 2026, the ETF attracted net inflows of US$1.1 million. By the end of that month, its total assets under management had reached US$47 million.

Should investors sell immediately? Or is it worth buying Brompton Global Healthcare H?

The fund, which was launched in 2015, carries a total expense ratio (TER) of 0.97 percent. The management fee component within that TER is 0.75 percent. Furthermore, the focus on global healthcare names offers a diversification benefit, as the sector is often underrepresented in many regional market indices.

Forward-Looking Perspective and Reporting

Brompton’s analysis positions the healthcare sector alongside low-volatility strategies as likely sources of outperformance in 2026. For investors seeking deeper insight into the fund’s current positioning, detailed portfolio compositions are provided through quarterly updates. These reports are typically published within 60 days following the end of a quarter. Consequently, the next update, expected by the end of May, will offer a fresh look at the strategic allocation of the fund’s top holdings.

Ad

Brompton Global Healthcare H Stock: New Analysis - 21 March

Fresh Brompton Global Healthcare H information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated Brompton Global Healthcare H analysis...

So schätzen die Börsenprofis Defensive Aktien ein!

<b>So schätzen die Börsenprofis  Defensive Aktien ein!</b>
Seit 2005 liefert der Börsenbrief trading-notes verlässliche Anlage-Empfehlungen – dreimal pro Woche, direkt ins Postfach. 100% kostenlos. 100% Expertenwissen. Trage einfach deine E-Mail Adresse ein und verpasse ab heute keine Top-Chance mehr. Jetzt abonnieren.
Für. Immer. Kostenlos.
CA11222T1057 | DEFENSIVE | boerse | 68946505 |